Functional validation of somatic variability in TP53 and KRAS for prediction of platinum sensitivity and prognosis in epithelial ovarian carcinoma patients
Concerning the dismal prognosis of chemoresistant patients with epithelial ovarian carcinoma (EOC), we aimed to follow up the findings of a previous whole-exome sequencing study using an orthogonal Sanger sequencing on the same patients and a separate set of 127 EOC patients (N = 177, all fresh froz...
Saved in:
| Main Authors: | Al Obeed Allah Mohammad, Ali Esraa, Krus Ivona, Holý Petr, Haničinec Vojtěch, Ambrozkiewicz Filip, Rob Lukáš, Hruda Martin, Mrhalová Marcela, Kopečková Kateřina, Bartáková Alena, Bouda Jiří, Spálenková Alžběta, Souček Pavel, Václavíková Radka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Cancer Biology & Therapy |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15384047.2025.2543105 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report
by: Vincent D. de Jager, MD, et al.
Published: (2024-12-01) -
KRAS signaling in malignant pleural mesothelioma
by: Antonia Marazioti, et al.
Published: (2021-12-01) -
Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer
by: Ella A. Eklund, et al.
Published: (2025-02-01) -
Evaluation of Tp–e interval, Tp–e/QT ratio, and Tp–e/QTc ratio in patients with Behçet's disease
by: Şıho Hidayet, et al.
Published: (2019-08-01) -
TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas
by: Yingao Zhang, et al.
Published: (2025-08-01)